Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)

BACKGROUND: The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study that evaluated the safety and efficacy of a three-dose pentavalent rotavirus vaccine (RV5) including its effect on healthcare utilization for rotavirus gastroenteritis (RVGE). The per-protocol (PP) analyses,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Itzler, Robbin, Koch, Gary, Matson, David O, Gothefors, Leif, Van Damme, Pierre, DiNubile, Mark J, Heaton, Penny M
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2905347/
https://ncbi.nlm.nih.gov/pubmed/20540778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-10-42
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars